![via itech.dickinson.edu](https://innovationtoronto.com/wp-content/uploads/2015/12/psilocomp11.jpg)
A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer according to a new study presented today at the annual meeting of the American College of Neuropsychopharmacology.
Patients who receive a cancer diagnosis often develop debilitating symptoms of anxiety and depression. Reports from the 1960s and 1970s suggest that hallucinogenic drugs such as LSD may alleviate such symptoms in cancer patients, but the clinical value of hallucinogenic drugs for the treatment of mood disturbances in cancer patients remains unclear. In this new study, Roland Griffiths and colleagues from the Johns Hopkins University School of Medicine investigated the effects of psilocybin on symptoms of anxiety and depression in individuals diagnosed with life-threatening cancer. Five weeks after receiving a dose of psilocybin sufficiently high to induce changes in perception and mystical-type experiences, patients reported significantly lower levels of anxiety and depression compared with patients that received a low dose of the drug. The positive effects on mood persisted in the patients at 6 month follow-up.
The authors suggest that a single dose of psilocybin may be sufficient to produce enduring decreases in negative mood in patients with a life-threatening cancer.
Read more: Active ingredient in magic mushrooms reduces anxiety and depression in cancer patients
The Latest on: Psilocybin
[google_news title=”” keyword=”psilocybin” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Psilocybin
- Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trialon July 24, 2024 at 9:06 am
The randomized, double-blind, placebo-controlled Phase IIb study will evaluate two therapeutic doses of nature-derived psilocybin (10mg, 25mg) against an active low-dose comparator (1mg) in 84 ...
- Lake Oswego voters to decide whether to bring psilocybin facilities to the cityon July 23, 2024 at 5:49 pm
The Lake Oswego City Council is bringing a psilocybin measure to the ballot in November, which will decide if psilocybin facilities are allowed in the city.
- Psilocybin reduces alcohol use by altering gene expression in brain’s reward centeron July 23, 2024 at 11:00 am
New research has found that psilocybin reduces alcohol consumption in rats by altering specific brain pathways, particularly in the left nucleus accumbens. This suggests that psilocybin could ...
- Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizureson July 22, 2024 at 9:00 pm
Vitamin D levels before starting treatment were tied to subsequent multiple sclerosis (MS) disease activity. (Journal of Neurology, Neurosurgery, and Psychiatry) Several brands of nootropic gummies ...
- Scientist Takes High Dose of Psilocybin, Clambers Into MRI Machine to Scan His Own Brainon July 20, 2024 at 4:30 am
Nico Dosenbach, an associate professor of neurology at Washington University School of Medicine in St. Louis, got to find out first hand what happens to the brain when it's on psychedelics. For ...
- Psilocybin reconfigures brain networks, showing potential for lasting therapeutic effectson July 18, 2024 at 8:38 pm
Researchers found that high-dose psilocybin significantly disrupts brain functional connectivity, particularly in the default mode network, with lasting effects linked to therapeutic benefits.
- Your Brain on Mushrooms: Study Reveals What Psilocybin Does to the Brain—and for How Longon July 17, 2024 at 5:00 pm
Magic mushrooms have recently had a reputation revamp. Often considered a hippie drug, their main active component, psilocybin, is being tested in a variety of clinical trials as a therapy for the ...
- This is your brain on psilocybinon July 17, 2024 at 2:05 pm
Psilocybin, also known as magic mushrooms, bolsters brain connections between self and memory, thus opening the mind to change, a new study found.
- New Insight Into Psilocybin's Therapeutic Potentialon July 17, 2024 at 12:35 pm
A single high dose of psilocybin results in dramatic changes to the brain's functional networks in new findings that offer novel insights into the therapeutic potential of psychedelics.
- We Can Now See How Psilocybin Changes the Brainon July 17, 2024 at 12:00 pm
Scientists tracked changes in brain activity after people took a large dose of psilocybin, finding clues on how the psychedelic drug might help treat depression.
via Bing News